Pyrethrum Pediculicide Labeling Revisions Would Provide More Detail – FDA

FDA's proposed amendment of the pediculicide drug products final monograph would appear to bring labeling for such drugs in line with that of OTC lice treatments approved under an NDA

More from Archive

More from Pink Sheet